FDA offers speedier approvals to drug companies aligning with 'national priorities'

On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an initiative that will apply to drugs that administration officials determine promote "the health interests of Americans."

👉 Full Story